Gene · 2249
Papers3,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective. | J Mol Med (Berl) | 2022 | 35606652 | PubTator, text mining | PubMed |
| RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality? | Front Oncol | 2022 | 35600358 | PubTator, text mining | PubMed |
| Xprediction: Explainable EGFR-TKIs response prediction based on drug sensitivity specific gene networks. | PLoS One | 2022 | 35584089 | PubTator, text mining | PubMed |
| Mutational landscape of nasopharyngeal carcinoma based on targeted next-generation sequencing: implications for predicting clinical outcomes. | Mol Med | 2022 | 35562651 | PubTator, text mining | PubMed |
| Prenatal glucocorticoid exposure selectively impairs neuroligin 1-dependent neurogenesis by suppressing astrocytic FGF2-neuronal FGFR1 axis. | Cell Mol Life Sci | 2022 | 35562616 | PubTator, text mining | PubMed |
| WNT and NOTCH signaling in human trophoblast development and differentiation. | Cell Mol Life Sci | 2022 | 35562545 | PubTator, text mining | PubMed |
| Tumor organoids: applications in cancer modeling and potentials in precision medicine. | J Hematol Oncol | 2022 | 35551634 | PubTator, text mining | PubMed |
| Reversing Epithelial Polarity in Pluripotent Stem Cell-Derived Intestinal Organoids. | Front Bioeng Biotechnol | 2022 | 35547177 | PubTator, text mining | PubMed |
| Emerging blood exosome-based biomarkers for preclinical and clinical Alzheimer's disease: a meta-analysis and systematic review. | Neural Regen Res | 2022 | 35535875 | PubTator, text mining | PubMed |
| Comparative genomic analysis of esophageal squamous cell carcinoma and adenocarcinoma: New opportunities towards molecularly targeted therapy. | Acta Pharm Sin B | 2022 | 35530133 | PubTator, text mining | PubMed |
| Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review. | Stem Cell Res Ther | 2022 | 35527304 | PubTator, text mining | PubMed |
| Refinement of computational identification of somatic copy number alterations using DNA methylation microarrays illustrated in cancers of unknown primary. | Brief Bioinform | 2022 | 35524475 | PubTator, text mining | PubMed |
| The DNA-Binding High-Mobility Group Box Domain of Sox Family Proteins Directly Interacts with RNA In Vitro. | Biochemistry | 2022 | 35511045 | PubTator, text mining | PubMed |
| Derivation of totipotent-like stem cells with blastocyst-like structure forming potential. | Cell Res | 2022 | 35508506 | PubTator, text mining | PubMed |
| Placental Tissues as Biomaterials in Regenerative Medicine. | Biomed Res Int | 2022 | 35496035 | PubTator, text mining | PubMed |
| Prognostic comparative genes predict targets for sorafenib combination therapies in hepatocellular carcinoma. | Comput Struct Biotechnol J | 2022 | 35495118 | PubTator, text mining | PubMed |
| Gene Mutations Associated With Clinical Characteristics in the Tumors of Patients With Breast Cancer. | Front Oncol | 2022 | 35494043 | PubTator, text mining | PubMed |
| Comprehensive analysis of DNA methylation for periodontitis. | Int J Implant Dent | 2022 | 35491409 | PubTator, text mining | PubMed |
| Mesenchymal Stem/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies. | Stem Cells Transl Med | 2022 | 35485439 | PubTator, text mining | PubMed |
| Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status. | BMC Med | 2022 | 35484593 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2249/papers?page=33